NL2029858B1 - Detection of a biomolecular process - Google Patents

Detection of a biomolecular process Download PDF

Info

Publication number
NL2029858B1
NL2029858B1 NL2029858A NL2029858A NL2029858B1 NL 2029858 B1 NL2029858 B1 NL 2029858B1 NL 2029858 A NL2029858 A NL 2029858A NL 2029858 A NL2029858 A NL 2029858A NL 2029858 B1 NL2029858 B1 NL 2029858B1
Authority
NL
Netherlands
Prior art keywords
strand
luminophores
dna
dna strand
handles
Prior art date
Application number
NL2029858A
Other languages
Dutch (nl)
Inventor
Paula Catharina Driessen Rosalie
Simonetta Marco
Original Assignee
Lumicks Dsm Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lumicks Dsm Holding B V filed Critical Lumicks Dsm Holding B V
Priority to NL2029858A priority Critical patent/NL2029858B1/en
Priority to PCT/EP2022/082010 priority patent/WO2023088906A1/en
Application granted granted Critical
Publication of NL2029858B1 publication Critical patent/NL2029858B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method of detecting a biomolecular process is provided. The method comprises: providing a DNA strand (11) comprising one or more luminophores (3) 5 attached to the strand (11) at one or more predetermined positions along the strand; attaching handles (7A, 78) to the DNA strand; and trapping and/or manipulating the strand (11) by manipulating the handles (7A, 7B) in a trapping setup. The method also comprises determining a position of at least one of the one or more luminophores (3) with respect to at least part of the trapping setup and determining on the basis of the 1 0 one or more luminophores (3) one or more of: a focus position of at least part of an optical detector and/or an illumination system; a focus position of at least part of an optical manipulator; a position of at least part of the strand (11); a position of a portion of the strand (11) relative to one or more other portions of the strand (11); a reaction or binding position on the strand (11) of a reagent interacting with the strand (11). The one 15 or more luminophores (3) are covalently attached to the DNA strand. An associated DNA strand is also provided. + Fig. 2 2 O

Description

33640-Fe/bk
Detection of a biomolecular process
TECHNICAL FIELD
The present disclosure relates to a method of detecting a biomolecular process.
BACKGROUND
Understanding and use of biomolecular processes require knowledge of molecular genomic information, such as properties of DNA sequences and of reagents such as proteins and/or other binding moieties interacting with a DNA sequence in a
DNA strand. Improvements of techniques for gaining such knowledge are therefore in high demand.
E.g. observing position-dependent interaction of a reagent with a DNA sequence may provide valuable information about the reagent and the other way around. Such information, which may comprise determining precise binding locations of molecules with respect to a genetic sequence (possibly down to the base pair level) and/or tracking motion of molecules as they move along a DNA strand can yield important insights into molecular mechanisms, specific versus non-specific/off-target binding, cooperative binding, on/off rates as function of binding location, etc.
Optical tweezers combined with fluorescence microscopy have shown to be valuable tools for such studies. See also for example Candelli et al., Phys. Chem.
Chem. Phys. 13:7263-7272 (2011), “Optical tweezers — methods and protocols”, A.
Gennerich (Ed.), Methods in Molecular Biology books series, Springer (2017) (DOI 10.1007/978-1-4939-6421-5), and WO 2019/151864.
However, exact localisation of a binding site along a DNA strand is cumbersome and it may even be impossible with present-day optical techniques.
Moreover, it has been found that binding of a reagent to a DNA strand may occur in other locations than expected, which may be due to physical and/or environmental factors; e.g. Newton et al. found that DNA stretching induces Cas9 off-target activity (Newton et al., Nature Structural & Molecular Biology, 26:185-192 (2019) — DOI https://doi.org/10.1038/s41594-019-0188-z).
The accuracy of determining binding locations of moieties in relation the
DNA sequence in such studies is currently limited by the accuracy of system calibrations, such as trap position, bead sizes and DNA tension. Furthermore, it can be challenging to focus the imaging system properly on the DNA strand to ensure all (single-molecule) binding events can be imaged properly for optimal localization.
Improvements to the determination of localization of a binding site of a reagent to the DNA strand are therefore desired.
SUMMARY
In view of the preceding, herewith is provided a method of detecting a biomolecular process, comprising providing a DNA strand comprising one or more luminophores attached to the strand at one or more predetermined positions along the strand; attaching handles to the DNA strand; and trapping and/or manipulating the strand by manipulating the handles in a trapping setup.
The method further comprises determining a position of at least one of the one or more luminophores with respect to at least part of the trapping setup; and determining on the basis of the one or more luminophores one or more of: a focus position of at least part of an optical detector and/or an optical excitation system; a focus position of at least part of an optical manipulator; a position of at least part of the strand; a position of a portion of the strand relative to one or more other portions of the strand; a reaction or binding position on the strand of a reagent interacting with the strand.
In the method, the one or more luminophores are covalently attached to the DNA strand.
By covalently attaching the one or more luminophores, risks of detachment and/or relocation of the luminophore along the strand are reduced compared to attaching one or more luminophores via other attachment techniques, such as antibody-antigen labelling (see e.g. Loparo et al., PNAS 108:3584-3589 (2011), DOI: www.pnas.org/cgi/doi/10.1073/pnas. 1018824108), enzymatic tagging, etc. Also, covalent binding of a luminophore to the DNA strand may be done well in advance of (an experiment comprising) the attachment of the handles to the strand. The method is therefore beneficial over in-situ labelling of specific sites on a DNA-molecule, e.g. using
BsoBl or EcoRV or Cas9 as exemplified in e.g. Heller et al., Chem.Phys.Chem. 15:727- 733 (2014), hips Ado org 100 cehe 201 3QR8 1G, since such known methods tend to require extra steps to incubate the DNA molecule with one or more purified proteins and/or guide RNA and such methods may require specific buffer conditions preventing experimental freedom. Also, or alternatively the binding of such known markers may depend on experimental conditions such as being tension dependent, so that off-target binding may occur and confound the analysis, e.g. see Newton et al. cited above. As a further example it is noted that e.g. ECORV may bind on Lambda-DNA in 21 different locations, and BsoB1 has 8 binding sites on Lambda DNA, relying on such labelling would therefore lead to a stochastic distribution of labelling sites rather than deterministic positions as presently provided. Moreover, there may be many binding sites for such enzymes which are separated apart less than microscopically resolvable (in particular point spread function) causing inherent uncertainty in any position determination relative to such labelling.
In the presently provided concepts, reliability of position determination on the DNA strand on the basis of the one or more luminophores is improved.
The luminophore may in particular be covalently bound to a single base in a sequence within the DNA strand. Thus, structural properties of the DNA strand may be affected at most to a small extent compared to a DNA strand without the luminophore. As an example, the luminophore may be attached to a thymine within the
DNA sequence. Preferably, the luminophore is attached to the DNA sequence so as not to interfere with the double strand structure and/or the helix-structure, e.g. being attached on another side than the interbase-binding side, such as opposite to an interaction side for an interbase-binding. E.g. when the luminophore is attached to thymine, the attachment should preferably be opposite to adenine or an interaction side for interacting with adenine in a double strand DNA.
The luminophore may comprise a fluorescent protein, a quantum dot, a chemiluminescent substance, a bioluminescent substance, a dye, in particular a synthetic fluorophore such as e.g. a dye from the ATTO, Alexa Fluor ®, Janelia Fluor ® or Cyanine dye families. These synthetic dyes typically provide high brightness (many photons/second) and/or a high photon budget (high average number of photons before bleaching) thus enabling a high localization precision.
The DNA strand may be provided as a basis for studies on the DNA strand itself and/or studies involving interaction of the strand with a reagent. The DNA strand may facilitate and/or simplify studies involving plural reagents. The DNA strand may be at least partly a single-strand DNA strand (ssDNA) but preferably it is at least partly a double-strand DNA (dsDNA).
The predetermined positions may be determined by design and/or manufacture of at least part of the DNA strand, e.g. by attaching the luminophore to a known site in a known sequence, such as by attaching the luminophore to a specific position on a known oligomer that is ligated into the DNA strand. Such attachment may be predetermined to the level of a single base, or single base pair, within a sequence in the DNA strand.
Determining a focus position of the optical detector and / or the optical excitation system on the basis of the one or more luminophores may improve optical studies. In particular in case of optical studies involving one or more reagents interacting with the strand, both the reagent and the strand may be detected optically and relative positions and/or movements thereof may be determined.
Determining a focus position of the optical detector may comprise focusing the optical detector on the luminophore, e.g. determining a minimum size of the luminophore in an image plane and/or determining a maximum intensity difference in an image plane between the luminophore and an environment thereof. The determination of the focus position may be with respect to one, two or three spatial directions, e.g. lateral and/or along a respective focused beam path. The determination of the focus position of the optical detector may comprise determining a relative position of the one or more luminophores with respect to one or more of the handles.
Also or alternatively, and similar to the preceding, the method may comprise determining a focus position of an illumination system, e.g. for at least partly illuminating the DNA strand. The illumination system may cooperate with, or be part of, the optical detector, e.g. for optical excitation of a luminophore and/or for microscopy techniques such as confocal microscopy, stimulated emission depletion (STED) microscopy, etc.
The optical detector may be configured for singular and/or repetitive detection e.g. for capturing single images and/or video sequences. 5 The optical detector and/or the illumination system may also be configured to scan along a one-dimensional scan line in order to allow efficient measurements with high time resolution, for example such as described in US 9 766 180 B2.
The optical detector and/or the illumination system may also or alternatively be focussed on a particular spot on the DNA strand. This may facilitate monitoring processes at or near, and/or with respect to, that spot. In combination with a high rate of capturing images, this may facilitate achieving a very high time resolution without a need to scan along the strand.
In case the DNA strand is provided with plural luminophores (see also below), the optical detector and/or illumination system may be focused on a first luminophore while detecting and/or illuminating (possibly exciting) one or more other (second) luminophores. Thus, the first luminophore may be used as a position marker, e.g. for detecting changes in, and/or or associated with, one or more of the second luminophores. Such changes may e.g. be indicative of a movement and/or manipulation of the DNA strand, which may be intentional (e.g. manipulation) and/or provoked (e.g. being a consequence of a method step) and/or accidental.
Similarly, determining a focus position of an optical manipulator may comprise determining a focus position of part of an optical tweezers setup, and/or of part of sample illumination system which may be configured for optical excitation of one or more of a part of the DNA strand, a reagent and a luminophore, etc. This may improve control over the strand and/or the reagent.
In current optical tweezers experiments, focusing is done is often done on the same signal/molecules as are the molecules under study. This is inefficient because this prevents separation of instrumentation properties and sample properties, e.g.: it may prevent determination whether a detected luminescence brightness variation is due to (de)focusing or a behaviour of the molecule(s) of interest. Also or alternatively, data obtained during the focusing may not be optimally usable to study the molecules of interest. Further, the molecules may bleach during the step of bringing the strand in focus. This may reduce or prevent obtaining useful data from such molecules.
Determining a position of at least part of the strand relative to one or more other parts of the strand may comprise determining one or more of an orientation, a length, and a shape of the DNA strand. E.g. one or more of (un-) winding, bending, knotting, and forking of (at least part of) the strand, on purpose and/or by accident, may be determined. In particular in case the DNA strand is provided with plural luminophores, . This may be particularly useful in assays where DNA strands are not tethered along a 1 dimensional straight line but are at least partially bent or knotted e.g. in assays involving more than two optical traps such as shown in, and described with respect to, Figure 2 of Brouwer et al., Nature, 535(7613):566-569 (2016), DOI: https://doi.org/10.1038/nature18643.
In particular in case the DNA strand comprises plural luminophores, detection of an orientation and/or a length and/or a shape of the strand may be simplified. In such case, a separation of at least some luminophores may be determined which may be used to determine a length of at least part of the strand and/or a length variation of at least part of the strand. At least some of the plural luminophores may have mutually different optical properties, e.g. having different absorption- and/or emission spectra. As an example, this may be used to determine an orientation (direction) of at least part of the strand, e.g. in the sense that it may be determined whether the part of the strand is oriented in one, two or three dimensions. This may be of relevance for an experiment since in general a sequence of at least part the strand may not be palindromic.
Determining a position on the strand of a reagent interacting with the strand may allow determination of a binding site of the reagent. The reagent may be or comprise proteins and/or protein complexes. To facilitate detection, such proteins and/or complexes may be provided with a fluorophore. E.g. by one or more of labelling with a fluorophore, by labelling with a fluorescent antibody or a quantum dot-modified antibody that recognizes the proteins of interest, by fusing to fluorescent proteins such as GFP.
By determining a position of a reagent relative to a luminophore of the strand, while the luminophore is covalently attached to the strand, a reliable relative position of the reagent and the strand may be determined and thus of the reaction position. E.g. a binding site of a protein to the strand may be determined with improved reliability, improving determination of binding structure and /or binding interactions in general.
The binding position may preferably be determined with a precision of less than 150 base pairs of the DNA strand or better, preferably less than 100 base pairs, e.g. less than 50 base pairs, possibly less than 30 base pairs.
The binding position may preferably be determined with a precision of better than 50 nm, preferably better than 30 nm more preferably better than 15 nm.
Currently, localization accuracy of part of the DNA strand and/or of binding positions of a reagent to the strand is (are) dependent on system calibrations, such as one or more of trap position, handle size (e.g. bead size) and DNA tension, any of which may require calibration in its own right. Such different factors tend to influence the localization accuracy and give it a certain offset and error.
The presently provided method enables determining positions on the basis of the strand itself and thus (at least largely) independent of the system and/or external factors. The one or more luminophores may provide for a calibration measurement under the same conditions, or at least similar conditions, as a measurement on the strand and/or one or more reagents of interest.
In case the strand comprises plural luminophores covalently attached to the strand at predetermined positions in the strand, the luminophores may provide improved spatial determination by providing plural reference positions.
Also or alternatively, the DNA strand may comprise one or more handle moieties for attachment to the handles.
In particular in case both the handle moieties and one or more sequences of interest elsewhere in the DNA strand comprise luminophores, the luminophore(s) of the handle moieties may differ from the luminophore(s) of the sequence(s) of interest, with respect to one or more optical properties, e.g. having different absorption- and/or emission spectra. This facilitates using selective detection. E.g., one or more first luminophores on the handle moieties may be excited by light of one colour, e.g. red light, and one or more second luminophores on or near sequences of interest may be excited by light with another colour, e.g. blue or green light. This may facilitate separate observation of the respective parts during an experiment and excitation of the first or second luminophore(s) may not affect the other (second or first, respectively) luminophore(s). This may e.g. be used to keep the DNA strand in focus of a detection system and/or to deterministically change one or more of the length, tension and position of the DNA strand on the basis of the first luminophores while preserving a limited photon budget of the second luminophores.
The DNA strand may comprise at least one handle moiety of more than 3000 base pairs, in particular more than 4000 base pairs, preferably more than 5000 base pairs such as more than 6000 base pairs. Preferably, the DNA strand comprises handle moieties of substantially equal length on opposite ends. Such long handle moieties facilitate separation of a handle to a sequence of interest in the DNA strand.
An end of a handle moiety could be marked with a luminophore and/or other label to simplify distinguishing between the handle moiety and a sequence of interest in the
DNA strand.
Manipulating the strand may comprise subjecting at least part of the strand to a predetermined tensile force and/or stretching at least part of the strand.
It has been found that stretching studies on DNA strands may provide valuable information on physical and/or (bio-)chemical properties of the strand. E.g. as indicated above, tension in a strand may affect binding properties of a reagent to the strand, e.g. binding site specificity, binding affinity, binding duration, processivity of a molecular motor, etc. The present method allows improved determination and/or use of such effect. Also or alternatively, tensioning may be used to study (effects of) coiling of the DNA strand and/or assist suppressing thermal fluctuation, e.g. see also WO 2019/139473, WO 2019/098839 and Candelli et al., Phys. Chem. Chem. Phys., 13:7263-7272 (2011).
By having the one or more luminophores attached covalently, e.g. ligated and incorporated by covalent bonds, the one or more luminophores are integrated into the DNA strand structure itself, at least to a high degree. Therefore, the attachment is robust against manipulation and stretching and the luminophore(s) will stay attached and not move along the strand. Also, the DNA strand may have a structural integrity comparable to a DNA strand without the one or more luminophores. The position of a luminophore along the DNA strand thus may be well known and stable under the manipulation so that it is a reliable beacon and which may serve as a reference for determination of other positions.
The luminophore may be attached to the DNA strand via a linker that is covalently attached to the DNA strand. E.g. an ATTO647N fluorophore may be covalently attached to thymine using a linking moiety (or commonly: “linker”), e.g. having a length of 5-25 atoms, preferably in a range 10-20 atoms such as in a range 10- 15 atoms. Note that, the shorter the linker, the better position determination of the DNA strand with respect to the luminophore may be. Suitable ATTO647N-labeled nucleotides with short linkers are available commercially.
A plurality of luminophores may allow determining of a distance between them. Therefore, accurate relative position information may be obtained and/or information regarding DNA length and/or stretching, thus also binding characteristics of a reagent related to DNA-length, stress, matching sizes, etc. E.g. plural luminophores in a single strand may serve as a ruler of sorts along the DNA strand, possibly allowing detection of uneven stretching of one or more parts of the strand relative to other parts of it.
Any embodiment may comprise determining a reaction position on the strand of a reagent interacting with the strand, wherein one or more luminophores are attached to the reagent, preferably covalently attached, and/or wherein the interaction of the reagent with the strand is associated with an optical process allowed to affect or caused to affect at least one luminescent property of at least one of the luminophores attached to the DNA strand.
When the reagent also comprises a luminophore and/or is associated with an optical process affecting a luminophore of the DNA strand, the reagent’s position may be determined with high reliably relative to one or more of the luminophores on the
DNA strand. The reaction position of a reagent interacting with the strand may be determined before, during and/or after a reaction, e.g. binding of a protein to the DNA strand.
This may allow restricting the field-of view of an imaging system to a precise location on the strand where one or more bindings and/or are expected, which may enable more efficient data collection and/or data collection at a higher time resolution. For example, the region-of-interest of an sCMOS or EMCCD camera may be limited only to a known location on the strand of just one or a few pixels wide, which enables acquisition at high frame rates. Similarly, a scanning laser excitation beam (e.g. a confocal excitation beam, a STED excitation beam or a multiphoton excitation beam) may be restricted to scan over only a very small region, e.g. scanning over a distance of less than a micron, and/or such laser beam may even be parked on a single location for only illuminating the location of interest, this may facilitate very high time resolutions.
An optical process affecting a luminophore of the DNA strand may comprise affecting at least part of an absorption spectrum and/or of an emission spectrum (e.g. changing an emission colour), affecting a bleaching behaviour (e.g. accelerating bleaching), affecting a blinking behavior, and/or allowing or rather inhibiting luminescence of the luminophore of the DNA strand altogether (switching, quenching, energy transfer, etc.). Such interaction may signal a binding behaviour of the reagent to the DNA strand.
Attachment of handles to the DNA strand may comprise attaching distinguishable handles to the strand, preferably optically distinguishable handles.
Suitable handles may be microbeads for optical tweezers, magnetic / magnetizable objects, electrically chargeable objects etc.
Also, or alternatively, at least some of the luminophores may have mutually distinguishably different optical properties, e.g. having different absorption- and/or emission spectra, scattering.
This allows or simplifies determining a direction of at least part of the DNA strand on the basis of the respective different optical properties. Thus, this allows or simplifies detecting and/or arranging a particular direction of the DNA strand and/or of a sequence within the strand. The method may comprise providing handles of different materials and/or handles comprising different functional groups. In particular in such case, the DNA strand may be provided with handle moieties being different for selective attachment to the different materials and/or the different functional groups. E.g. one end of the DNA strand may be provided with biotin, whereas an opposite end of the DNA strand may be provided with digoxigenin, for selective attachment of streptavidin and, respectively, anti-digoxigenin provided beads to the respective ends as different handles. Distinguishability of the handles may e.g. be due to one or more of size, shape, colour, reflectivity, transmissibility or opaqueness, magnetic response, etc.
Different handles may also be deterministically picked up by different traps of a multi- trap setup such as an optical tweezers setup. E.g. the respective beads may be selected using a laminar flow system as shown in, and described with respect to, figure 7B of WO 2014/196854 A1, so that for example one trap contains a streptavidin-
coated.bead while the other trap contains an anti-digoxigenin-coated bead, and the
DNA strand is trapped with a well-determined directionality.
Any embodiment may comprise determining a time dependent behaviour of at least one of a position of at least part of the strand; a position of a portion of the strand relative to one or more other portions of the strand; and a reaction position on the strand of a reagent interacting with the strand.
Thus, better understanding of the respective behaviour and/or the respective behaviours with respect to each other may be obtained.
The determination of the time dependent behaviour may comprise repetitive determination of the respective position associated with determining time periods.
Determining a time dependent behaviour may be facilitated by visualising results of repeated determinations in a kymograph and/or a movie clip. Also or alternatively, determining a time dependent behaviour may comprise determining binding durations and/or determining dwell time. Analysis of determined data may comprise recording and/or analysis of moving and/or static images and use of statistical techniques such as histograms.
In any embodiment the step of providing the DNA strand may comprise one or more luminophores covalently attached to the strand at one or more predetermined positions along the strand may comprise the steps of providing an oligomer, covalently attaching a luminophore to the oligomer thus providing an optically labelled oligomer; providing a double strand DNA strand; replacing a sequence from the DNA strand with the optically labelled oligomer.
This may facilitate determining a location of the luminophore on and/or in the DNA, in particular relative to at least another part of the DNA strand. Attaching a luminophore to an oligomer facilitates determining the location of the luminophore, e.g.
since oligonucleotides can be easily synthesized and labelled with a fluorophore in a specific position of the oligonucleotide sequence.
Further, replacing a sequence in a double strand DNA by an oligomer, in particular for non-palindromic sequences and oligomers, provides a well-determined position of the oligomer into the DNA strand, e.g. by requiring multiple base pair matchings between the oligomer and an associated part of the DNA strand, and therefore a position of the luminophore may be determined with a high precision. E.g.
Lambda DNA can be labelled using a short fluorophore-modified oligonucleotide which is complementary with a unique sequence in the Lambda DNA that can be removed from the Lambda dsDNA after nicking. The fluorophore-modified oligonucleotide can be incorporated instead of the removed sequence into the Lambda DNA. Subsequent ligase covalently binds the oligonucleotide to the Lambda DNA. Thus, the fluorophore is ultimately covalently attached the DNA sequence of Lambda.
The DNA strand may comprise a lesion at a predetermined position with respect to the position of the one or more luminophores. Thus, the lesion and any effect thereof on an interaction with a reagent may be determined accurately, whereas the lesion itself may not be visible or otherwise detectable during an experiment. Note that such DNA strand may comprise a plurality of lesions each at a predetermined position with respect to the position(s) of the one or more luminophores
It is noted that also or alternatively, DNA strands may be compared that have each identical sequences and have each a luminophore covalently attached to the same base, but otherwise differing in that a first one of the DNA strands to be compared has a second luminophore covalently attached to it at a second location along its strand, whereas another one of the DNA strands to be compared has a lesion at the second location along its strand, instead of the second luminophore. Thus, the location of the (invisible) lesion can be more accurately determined by comparison.
In view of the preceding, herewith also a DNA strand is provided for any method disclosed herein.
The DNA strand comprises a plurality of luminophores covalently attached tothe strand at a plurality of predetermined positions along the strand, and/or the DNA strand comprises one or more luminophores covalently attached to the strand and one or more lesions at a predetermined position with respect to the position of the one or more luminophores. The DNA strand is provided with handle moieties for attachment to trappable and/or manipulatable handles, e.g. polystyrene beads for optical trapping, magnetic beads for magnetic trapping, etc.
By providing the plurality of luminophores and/or the combination of one or more luminophores and one or more lesions, as specified, accurate position determination of at least part of the DNA strand and/or a reagent is facilitated. By provision of the handle moieties, the DNA strand may be provided with the handles for the trapping and/or manipulating.
The handle moieties may be different for selective attachment to distinguishable handles. This allows or simplifies detecting and/or arranging a particular direction of the DNA strand and/or of a sequence within the strand, as indicated before.
The plurality of luminophores may be attached substantially equidistant along the DNA strand.
Also or alternatively, the DNA strand may comprise a plurality of substantially the same sequences, each of the sequences being may be provided with one or more of the plurality of luminophores covalently attached to the sequence; then, the plurality of substantially the same sequences may be oriented the same along the
DNA strand.
Either or both simplifies detection of (changes in) separation between at least some of the luminophores. This also facilitates studying properties and/or behaviour of the strand under manipulation of the strand and/or attachment of a binding moiety to the strand. In particular this may allow studying differences in properties and/or behaviour of different portions of the strand when subject to tension.
The equidistance may be determined in terms of numbers of base pairs and/or sequences and/or functional units along the strand, e.g. genes.
At least some of the luminophores may have mutually different optical properties, e.g. having different absorption- and/or emission spectra, scattering. Also or alternatively the strand may be provided with handles having mutually different optical properties, e.g. having different absorption- and/or emission spectra, scattering.
Either or both may assist identifying directionality of the DNA strand and/or identifying particular (groups of) luminophores, which may assist identifying particular portions and/or sequences of the DNA strand and/or simplify determining one or more of position, shape and length of at least part of the strand.
BRIEF DESCRIPTION OF THE DRAWINGS
The above-described aspects will hereafter be more explained with further details and benefits with reference to the drawings showing a number of embodiments by way of example.
Figs. 1, 1A and 2 schematically indicate method steps of providing a DNA strand as disclosed herein;
Fig. 3 schematically indicates an experimental system for performing part of the method as disclosed herein;
Figs 4A, 5A and 6A are confocal microscopy images of DNA strands as disclosed herein provided with handles and being optically trapped and tethered;
Figs 4B, 5B and 6B are schematic depictions of the DNA strand imaged in
Figs 4A, 5A and 6A, respectively; Figs. 5C, 5D indicate method steps of providing such
DNA strand;
Fig. 7A shows a two-colour confocal fluorescence 2D image of a DNA molecule tethered between two optically trapped beads; Fig. 7B is a negative grayscale version of Fig. 7A;
Fig. 7C is an intensity plot of two colour channels of the confocal fluorescence image of Figs. 7A, 7B;
Fig. 7D is a kymograph of the setup of Figs. 7A-7C;
Fig. 8A-8D indicate different methods of determining a Cas9-binding site from kymographs as in Fig. 7D;
Fig. 9 indicates determining a position of a luminophore of the DNA strand from the position of other luminophores of the DNA strand;
Fig. 10 is kymograph showing dynamic binding processes.
DETAILED DESCRIPTION OF EMBODIMENTS
It is noted that the drawings are schematic, not necessarily to scale and that details that are not required for understanding the present invention may have been omitted. The terms "upward", "downward", "below", "above", and the like relate to the embodiments as oriented in the drawings, unless otherwise specified. Further, elements that are at least substantially identical or that perform an at least substantially identical function are denoted by the same numeral, where helpful individualised with alphabetic suffixes.
Further, unless otherwise specified, terms like “detachable” and ‘removably connected” are intended to mean that respective parts may be disconnected essentially without damage or destruction of either part, e.g. excluding structures in which the parts are integral (e.g. welded or molded as one piece), but including structures in which parts are attached by or as mated connectors, fasteners, releasable self-fastening features, etc.
Fig. 1 schematically indicates method steps of providing a DNA strand 1 with a luminophore 3 at predetermined position in the strand 1 to provide a DNA strand 11 comprising the luminophore 3 attached to the strand 11 at a predetermined position along the strand.
In step 1, indicated in the top row, a double strand DNA strand (“dsDNA”) molecule 1 is provided. For simplicity, a helical structure of the dsDNA is not indicated.
The dsDNA strand 1 comprises a main section 4 which is provided with handle moieties 5 on opposite ends of the section 4, e.g. one or more biotins on each end. Fig. 2 schematically indicates a DNA strand provided with different handle moieties such as a biotin-containing sequence 5A on one end and a digoxigenin-containing sequence 5B on another end, to which handles 7A and 7B are attached, see also below.
In step 2, the dsDNA strand 1 is nicked. E.g., using Cas? nickase, which is highly position specific (second row). Also or alternatively, other nicking endonucleases could be used, e.g, Nt.BstNBI. The nicking defines a short single stranded fragment in one of the single strands of the dsDNA strands (not shown). The ss-strand is liberated from the dsDNA providing a gapped dsDNA 1g (third row).
Next, modified oligomers 6 are provided (fourth row), which oligomers have the same sequence as the liberated ss-strand. The modified oligomers are provided with a luminophore 3 covalently attached to a base in the oligomer sequence.
Tyically, oligomers with a length of 10 nt to 30 nt may be used, preferably with a length 13 nt to 24 nt.
The modified oligomers are annealed into (the gaps of) the gapped dsDNA and ligased into the dsDNA strand. Thus, a luminophore-containing dsDNA strand 11 is provided, comprising a luminophore covalently attached to the strand at a predetermined position along the strand (fifth row). Here, the luminophore is located offset from a middle of the strand, at about 30% of the length of the dsDNA strand.
In another example, shown in Fig 1A, an initial dsDNA strand is provided, e.g. a Lambda DNA of 48,5 kb length. As an option, the initial dsDNA strand is first provided with biotinylated oligomers by annealing and ligasing to the natural overhangs of the Lambda DNA (top row).
Next (second row), the dsDNA strand was nicked in plural positions using
Nt.BstNBI. By incubating at 75 °C for 2 minutes DNA fragments of 13 nt and 17 nt are lost, providing the DNA strand with plural gaps. Then, plural oligomers each complementary to the remaining single strand sequence of the DNA strand and comprising a fluorophore such as ATTO647N (commercially available), were annealed by slowly cooling down from 75 °C to 22 °C at a ramp rate of 0.2 °C per second into the thus-formed gaps so that the resultant modified dsDNA strand comprised plural luminophores covalently attached to the strand at predetermined positions along the strand.
Note that any luminophore-containing oligomer ligased into the DNA strand as described above may itself serve as, or provide, a sequence of interest and/or it may serve to provide the luminophore into the DNA strand 11 for reference to a/another sequence of interest.
The dsDNA may be plasmid dsDNA or lambda phage DNA, and the handles could be provided to naturally occurring ssDNA overhang ends, e.g. using dNTPs.
Next after preparation of the luminophore-containing DNA strand 11 handles 7 are attached to the luminophore-containing DNA strand 11, as indicated in
Fig. 2. In Fig. 2, each individual handle 7A, 7B is a bead provided with conjugate moieties to the respective different handle moieties 5A, 5B of the strand 11. The beads
TA, 7B may be the same or may be distinguishable, e.g. being at least partially of different material or a different size (see different hatchings).
The beads 7A, 7B may be trapped in optical traps provided by focused laser beams thus tethering the DNA strand 10 between the beads. The trapping system may, e.g., be a system as generally discussed in WO 2014/196854, WO 2016/129994 or in WO 2020/130812.
E.g. Fig. 3 schematically illustrates an embodiment of a suitable trapping and microscopy system 1000.
The system 1000 comprises a sample holder 100 for holding a sample, a trap system 70, as options an excitation system 170 and a depletion system 250, an imaging detector 220 and a controller 300 as an option being connected to each of these systems (only partly shown).
The optical system 1000 comprises a trap system 70 for establishing an optical trap that can hold an object such as a bead 7 to which an object such as a DNA strand 11 may be connected; in particular, the trap system may be configured for a dual optical trap holding two objects 7, such as beads, simultaneously with the DNA strand 11 connected between them, as shown in the enlarged detail in Fig. 3 and in Fig. 3A.
Optical traps are known in the prior art. An example of an optical trap is described in Ashkin et al., Opt Lett 11:288 (1986). doi: 10.1364/0L.11.000288, and in the afore mentioned WO 2014/196854, WO 2016/129994 and WO 2020/130812.
Typical bead sizes ranges used in optical experiments may vary from 100 nanometer to 5 micrometer.
In one embodiment, the trap system 70 comprises a trap light source 10 for generating trapping light. The trap light source 10 may be a laser, e.g. a 1064 nm
CW laser, although numerous other types of laser sources are suitable as well. Further, trap system 70 may comprise various optical elements such as a module 20 for rotating a polarization of the trapping light and a polarizing beam splitter 30 for splitting the trapping light into two light beams 80, 85, one for establishing a first trap and a second for establishing a second trap. The light beams are transmitted through an optical system (not indicated) comprising optical elements such as lenses, mirrors, polarizers, pinholes, etc. to direct and shape the respective beam 80, 85 suitably for forming a trap.
In each trap, the trapping light 80, 85 provides an optical trapping force onto the bead 7 by which the bead 7 is held in the trap; see Fig. 3A.
In addition, the trap system 70 may comprise a module 40 for controlling the position of the first trap and a module 50 for controlling the position of the second trap. In particular, independent trap steering may be done via a coarse-positioning piezo stepper mirror in one of the modules 40, 50 and an accurate piezo mirror for the respective traps, in the other one of the modules 40, 50. A (polarizing) beam splitter 60 may be used to recombine the individually controlled trapping beams. The trapping beams are focused by an objective 90 into the sample holder 100 containing a sample, here containing beads 7 with the strand 11. If the trap system 70 is configured to establish two traps, as shown, advantageously the object of interest in the sample, here: the DNA strand 11, can be held fixed between two optically trapped object such as beads 7. The position of each bead may be determined and/or controlled in one, two or, preferably, three dimensions X, Y, Z as indicated in Fig. 3A. As discussed in more detail in WO 2014/196854, in an embodiment, one or more telescopes (not shown) may be present in the optical path for properly projecting the beams from (the tip/tilt mirrors of) the modules 40 and 50 onto the back focal plane of the objective 90. Thus, the respective beam may be expanded and/or convergence of the beam may be controlled.
This may facilitate overlaying a trapping focal plane and an imaging focal plane onto each other (see also below).
As another option, not shown, the trap system may be configured for one or more other optical traps, e.g. a quadruple optical trap for holding four objects 7, such as beads, simultaneously as discussed in WO 2016/129994, wherein the DNA strand 11 and one or more sample portions may be connected between respective ones of the objects. In the system, one or more, preferably each of the traps may be manipulated independently. Such arrangement also allows engagement and/or entangling and/or knotting of two DNA strands each connected to two beads. Note that entangling and/or knotting may comprise three-dimensional manipulation (X, Y, Z-direction); the present methods and systems facilitate detecting, monitoring and/or controlling position and/or movement of parts of the respective DNA-strands in all three dimensions due to the luminophore(s). Covalent attachment of a luminophore, instead of other attachment techniques, such as antibody-antigen labelling, reduces risks of detachment from the
DNA strand during manipulation for such entanglement and/or knotting.
The shown optical system 100 comprises, as an option, a force detection system 120, that is configured to detect a force exerted by at least one of the traps established by trap system 70 on the trapped object. The force detection system 120 shown comprises a condenser lens 130 that collimates the trapping beams and directs them towards a force detection module 140 for detecting a force exerted by the first trap and optionally a force detection module 150 for detecting a force exerted by the second trap. As known in the art, these modules 140 and 150 may be position dependent sensors as the force can be determined based on a deflection of the trapping light and using back-focal plane interferometry. A polarizing beam splitter 160 may be used to separate the trapping beams from the first and second traps.
Thus, the system allows subjecting at least part of the strand 11 to a predetermined tensile force and/or stretching at least part of the strand 11. However, it is noted that according to the present concepts, a tensile force need not be known while one or more positions and/or separations of (parts of) the DNA strand and/or objects relative to the DNA strand may still be reliably determined due to the luminophore(s).
The optical system 1000 may further comprise an illumination optical system. In particular, as shown an excitation optical system comprising an excitation light source 170 may be provided, such as an excitation laser having a suitable wavelength for exciting a luminophore of the DNA strand. In particular, for exciting dye molecules of ATTO647N, a laser having a wavelength of 639 nm may be used. The excitation optical system 170 may be configured to focus excitation light 180 onto the sample portion of interest (here: strand 11) through the objective, for example by reflection of an optional dichroic mirror 190. The excitation light 180 may excite molecules and/or one or more luminophores 3 in the sample, possibly dependent on a tight focusing or not of the excitation light beam 180; see Fig. 3A. A focus position of the excitation light 180 relative to at least part of the DNA strand 11 may be determined by determining the focus position relative to at least one luminophore 3 of the DNA stand 11, e.g. in a direction X along the DNA strand, and/or in a direction Z along a direction of propagation of the beam of excitation light 180 and/or in a direction Y perpendicular to both the strand and the direction of propagation of the beam of excitation light 180 (see bold arrows in Fig. 3A). In case of a laser scanning imaging system, such as e.g. a confocal laser scanning system, one or more beam scanning optical elements such as e.g. scan mirrors may be provided including any required relay telescopes or lens systems. The excited molecules may subsequently decay and emit fluorescence light.
Fluorescence emission 200 may be collected by the objective 90 and may be directed towards a detector 220, e.g. by dichroic mirrors 190 and 210. The detector may comprise an avalanche photodiode, a photomultiplier, but a (possibly digital} camera or other detector is also conceivable.
As an option, the optical system 1000 may be configured for STED microscopy. E.g., the system 1000 may then further comprise a depletion light source 250, e.g. a laser, in particular, for depleting excited molecules ATTO847N a laser having a wavelength of 767 nm may be used. The depletion light source 250 may generate a depletion beam 260 which passes through an optional optical beam shaping element, e.g. a phase mask 270, which may imprint a desired intensity pattern on the beam, e.g. determining a local intensity minimum in the beam focus. In the shown example, the beam path of the depletion beam 260 is combined and overlapped with the beam path of the excitation beam 180 at a dichroic mirror 280, but a polarizing beam splitter and/or another combiner may also be used. This may simplify arranging an overlap of a focus of the depletion beam 260 and of a focus of the beam of excitation light 180 (Fig. 3A). As discussed in more detail in WO 2014/196854 one or more telescopes (not shown) may be present in the optical path of the illumination and /or detection system in order to properly project the beams from any beam scanning mirrors onto the objective back focal plane, to possibly expand the beam and to control the convergence of the beam and thereby allow the imaging focal plane to be overlayed onto the trapping focal plane.
Also, one or more further optical systems for excitation and/or detection may be provided.
The sample may comprise reagents 13, e.g. proteins which may be provided with luminophores.
The system allows optical detection of the luminophore of a DNA strand and possibly also optical detection of the beads between which the DNA is tethered; e.g. Figs. 4A and 4B show a microscopy image and a schematic depiction, respectively, of a48.5 kb Lambda phage DNA comprising a single luminophore, as an example:
ATTOB47N. In Fig. 4A, the sample was illuminated with red (laser) light at 658 nm, causing the fluorescence captured in the image. The position of the luminophore is clearly discernible, whereas the shapes and positions of the beads 7 are less well defined. The DNA strand itself is not visible.
Figs. 5A, 5B show, respectively, like Fig.s 4A, 4B a (fluorescence) microscopy image and a schematic depiction of a DNA strand 11 comprising a single luminophore 3 (again: ATTO8647N illuminated with 658 nm light as example, but it will be apparent to the reader that other luminophores and/or excitation light colours may be used suitably). Here, the DNA strand 11 comprises a main section 4 that is a relatively short sequence of only 3 kb length; however, the handle moieties 5A, 5B are relatively long, about 6 kb. The length of the handle moieties allows separation between the handles (beads 7) and the sequence of interest; thus increasing detectability of the luminophore and preventing interaction between the handles and the sequence of interest. Note that the handle moieties may be configured to prevent interaction between a handle sequence and a reagent in the sample (not shown). Figs. 5C, 5D indicate method steps of providing such DNA strand.
In Fig. 5A, is visible that the luminophore fluoresces in red light whereas the beads serving as handles for optical tweezers autofluoresce in green light under the excitation illumination. Such spectral difference increases contrast between the handles and the luminophore, further improving detection of the luminophore and/or any reactions affecting luminescence of the luminophore.
Fig. 5C shows a dsDNA section 4 provided with a covalently bound luminophore 3 and having overhanging ssDNA ends 8A, 8B, which may be palindromic but preferably are non-palindromic. Here, the luminophore 3 is ATTO 647N, but other luminophores may be used. Further, handle moieties 5A, 5B are indicated, each comprising having overhanging ssDNA ends 9A, 9B, complementary to the ends 8A, 8B.
Fig 5D shows that the handle moieties 5A, 5B are ligated to the dsDNA section 4 by connection of the respective overhanging ends 8A, 9A; 8B, 9B, thus forming a dsDNA strand 11 comprising a luminophore 3.
The handle moieties 5A, 5B are long, here they are 6000 base pairs long, as indicated. Here, each of the handle moieties 5A, 5B is provided with 3 biotin molecules, for attachment to streptavidin-conjugated handles (see Figs 5A, 5B).
Figs. 6A, 6B show respectively, a microscopy image and a schematic depiction of a DNA strand 11 comprising a plurality of luminophores 3. The DNA strand comprises a tandem repeat of oligomers of about 3 kb length. Further, the strand 11 is provided with different handle moieties 5A, 5B on opposite ends, e.g. digoxigenin and biotin, respectively. Optically distinguishable handles 7A, 7B have each been provided with different attachment moieties for attachment to the handle moieties, e.g. anti- doxigenin and streptavidin, respectively, and these have been attached to the strand 11.
Thus, when trapped, the directionality of the DNA strand is detectable, see Fig. 6A. In this example, the luminophores appear to be arranged equidistant along the strand 11, indicating that the oligomers are unidirectionally arranged in the DNA strand 11.
A tethered DNA strand may be analysed in various ways as known in the art, e.g. by making kymographs and/or intensity line scans of a series of successive images. The one or more luminophores may provide a reference in at least part of the images, e.g. facilitating alignment of successive images and/or linescans thereof. Thus facilitates reduction or removal of experimental imprecision and/or noise, e.g. by improved averaging. Displacement of a protein with respect to a luminophore may be identified reliably.
For instance Fig. 7A shows a 2D image (like Figs. 4A, 5A, 6A) of a DNA molecule tethered between two optically trapped beads 7 (bead diameter 4.38 micrometer). The DNA molecule is a Lambda dsDNA strand and includes three fluorescent markers as luminophores 3 (red, ATTO647N). The beads 7 show autofluorescence at their respective centres 7M. A Cas9 molecule labelled with another fluorophore (green, ATTO565) is bound to its target site along the DNA strand; the location is indicated with “C”. In a colour image the difference is clearly visible. Fig. 7B is a grayscale negative image of Fig. 7A; also here the respective luminophores 3 and (the fluorescent label of) the Cas9 are clearly visible. Fig. 7C indicates optical intensity of red and green light, respectively (red: solid line; green: dashed line) along a trace L in the image of Fig. 7A/7B, typically a line scan along the line of highest intensity. Such analysis may be done on the basis of camera images and/or on the basis of images of dedicated detectors which may comprise line scanners. Fig. 7C shows the result of separate detectors used to analyse the red and green light respectively (“red channel”; “green channel’). Since in the used setup part of the fluorescence of the ATTO565 is detectable in the red channel as well due to its emission spectrum, the position of the
Cas9 is visible in both detector signals (here, at about pixel position 260). This may serve for (checking) alignment of both traces.
Fig. 7D shows a grayscale kymograph over more than 30 seconds of the
DNA strand with the Cas9 molecule attached to it. For ease of reference, the image of
Fig. 7B is included as well, rotated by 90 degrees. Clearly, the relative positions of the luminophores are constant, reflecting a stable configuration of the DNA strand and the
Cas9 bound to the DNA strand. From the line traces (Fig. 7C) and/or from the kymograph (Fig. 7D) positions of the respective portions may be determined, e.g. as follows:
Each of Figs. 8A-8D and 9 indicates an intensity profile as in Fig. 7C from kymographs as shown in figure 7D. In the experiments, the used lambda DNA strand and the Cas9 molecule were the same. The thee ATTO647N fluorophore molecules were covalently attached to Thymine bases in the DNA strand at genomic positions
10848, 33786 and 44826, respectively. The target binding site of the Cas9 on the lambda DNA was predetermined to be at genomic position 18084 along the strand.
Further, in the used the experimental conditions and employing about 10 pN tensile force to the DNA strand 11, a length scale of 0,34 nanometers per base pair of the DNA strand applies.
In Fig. 8A the binding site of the Cas9 was determined using edge detection of the autofluorescence of the beads 7. The autofluorescence of the beads 7 is unpredictable and could lead to higher inaccuracies when the autofluorescence signal is relatively low. The determined Cas9 binding site using this method was at genomic position 17617. This method therefore leads to a determined binding site with an offset of 467 base pairs (or: about 159 nm) from the target binding site.
In Fig. 8B, the binding site of the Cas9 was determined based on fitting the intensity peaks on the bead centers 7M. The intensity peaks on the beads are not always visible which makes this an unreliable method to use for localization determination. The determined Cas9 binding site using this method was at genomic position 18518. This method therefore leads to a determined binding site with an offset of 434 base pairs (or: about 148 nm) from the target binding site.
In Fig. 8C, the binding site of the Cas9 was determined based on fitting the intensity peak from 1 fluorescent marker (i.e. a luminophore 3) and using the distance between the beads 7 from bead tracking in the brightfield camera image (not shown). Determining the distance between the beads from the bead tracking is dependent on brightfield versus confocal distance calibration. The determined Cas9 binding site using this method was at genomic position 18205. This method therefore leads to a determined binding site with an offset of 121 base pairs (or: about 41 nm) from the target binding site.
In Fig. 8D, the binding site of the Cas9 was determined based on fitting the intensity peak from two fluorescent markers (i.e. two luminophores 3). The determined Cas9 binding site using this method was at genomic position 18149. This method therefore leads to a determined binding site with an offset of 65 base pairs (or: about 22 nm) from the target binding site.
Clearly, use of one luminophore as provided herein significantly increases accuracy of determining a binding site compared to known methods. Use of two luminophores as provided herein provides yet another significant improvement over using only one luminophore.
In Fig. 9, as a further check of the present concepts, the location of one of the luminophores was determined based on the positions of two other luminophores; in particular the position of the middle marker was determined using the intensity profiles of the two outer fluorescent markers to show the accuracy of the localization determination method. The luminophore under consideration was known to be at genomic position 33786. The determined position using this method was at genomic position 33799. This method therefore leads to a localization determination of the fluorescent marker with an offset of only 13 base pairs (or: about 4 nm) from the actual position.
Without wishing to be bound to any particular theory, it is believed that the further accuracy of the determination of the middle marker (Fig. 9; 13 base pairs offset) compared to the accuracy of the Cas9 binding site (Fig. 8D; 65 base pairs offset) in the present test-experiments may be the result of experimental origins such as noise and/or alignment inaccuracies between the red- and green- wavelength detectors in the used setup, and/or the result of inherent origins such as structural artefacts of the respective
Cas9 molecule and its fluorophore and/or an offset in the actual DNA strand binding site of the fluorescent moiety of the Cas9, which may be at least partly resolved in further research and experimental and/or by appropriate correction when processing the experimental data (e.g. using a correction factor and/or software development).
The position of a lesion on the DNA may strand replacing a luminophore may therefore also be determined with very high precision.
Fig. 10 indicates use of the method for determining and/or quantifying binding kinetics. Fig. 10 is a kymograph of spanning about 80 seconds of a same DNA molecule provided with covalently attached luminophores 3 (red, ATTO647N; two luminophores 3 active, one bleached but its known position indicated with a dashed line) tethered between two beads 7 (4.38 um diameter) as in Figs. 7A-9. In Fig. 10 is also visible (a trace of) an optically labelled (green, ATTO565) Cas9 molecule 13 which is movably bound to the DNA strand, but not tightly bound to its target site. Clearly visible in the Figure, during the experiment the Cas9-molecule 13 moves along the DNA strand, “searching” until it locates its target site and binds to that at and after about 69 seconds of the kymograph; the target site is marked CT.
Also is visible that at a time of about 41 seconds, another Cas9 molecule (also optically labelled in the same way — indicated as 13a) binds to the Cas9-target site of the DNA strand, producing two Cas9 traces (green in a colour image, see separate indication). However, that other Cas9 molecule 13a detaches again from the DNA strand and disappears from view at a time of about 50 seconds. Then, the target binding side is left free for subsequent occupation by the Cas9 molecule 13 considered from the start in the kymograph.
Further, it may be discerned that at the position marked Ct the Cas9 molecule 13 under consideration appears to have a larger dwell time than elsewhere along the DNA (except for the target binding site). This may indicate a less-preferred binding site; modification of experimental conditions, e.g. stretching or relaxing the DNA strand somewhat may transfer such less-preferred binding site to a strongly-preferred binding site or the other way around (cf. the paper by Newton (2019) cited in the beginning).
From Fig, 10 may be understood that the luminophores 3 covalently attached to the DNA strand provide a constant and reliable reference for determination interaction location, binding location and/or dynamics of molecules and/or other reagents with the DNA strand. A further advantage of using multiple covalently attached luminophores as references is that this provides some redundancy in that when some of the luminophores bleach or are otherwise absent others may still be used as reference marker.
The disclosure is not restricted to the above-described embodiments which can be varied in a number of ways within the scope of the claims. Elements and aspects discussed for or in relation with a particular embodiment may be suitably combined with elements and aspects of other embodiments, unless explicitly stated otherwise.

Claims (14)

CONCLUSIESCONCLUSIONS 1. Een methode voor het detecteren van een biomoleculair proces, omvattende: het verschaffen van een DNA-streng (11) die één of meer luminoforen (3) omvat die op één of meer vooraf bepaalde posities langs de streng (11) aan de streng (11) zijn bevestigd; het bevestigen van handvatten (7; 7A, 7B) aan de streng (11); het vangen en/of manipuleren van de streng (11) door het manipuleren van de handvatten (7; 7A, 7B) in een vangopstelling (1000); waarbij de methode verder omvat: het bepalen van een relatieve positie van ten minste één van de één of meer luminoforen (3) en ten minste een deel van de vangopstelling (1000); en het op basis van een of meer luminoforen (3) bepalen van een of meer van: een focuspositie van ten minste een deel van een optische detector (220) en/of een verlichtingssysteem (170; 250); een focuspositie van ten minste een deel van een optische manipulator (70); een positie van ten minste een deel van de streng (11); een positie van een deel van de streng (11) ten opzichte van een of meer andere delen van de streng (11); een reactie- of bindingspositie op de streng (11) van een reagens (13) dat een interactie aangaat met de streng (11); waarbij de een of meer luminoforen (3) covalent aan de streng zijn bevestigd.A method for detecting a biomolecular process, comprising: providing a DNA strand (11) comprising one or more luminophores (3) attached to the strand at one or more predetermined positions along the strand (11). (11) are confirmed; attaching handles (7; 7A, 7B) to the strand (11); capturing and/or manipulating the strand (11) by manipulating the handles (7; 7A, 7B) in a capture arrangement (1000); the method further comprising: determining a relative position of at least one of the one or more phosphors (3) and at least a portion of the capture array (1000); and determining, based on one or more phosphors (3), one or more of: a focus position of at least part of an optical detector (220) and/or an illumination system (170; 250); a focus position of at least a portion of an optical manipulator (70); a position of at least a portion of the strand (11); a position of a part of the strand (11) relative to one or more other parts of the strand (11); a reaction or binding site on the strand (11) of a reagent (13) interacting with the strand (11); wherein the one or more luminophores (3) are covalently attached to the strand. 2. De methode volgens conclusie 1, waarbij een van de een of meer luminoforen (3) covalent is bevestigd aan een enkele base in de DNA streng (11).The method according to claim 1, wherein one of the one or more luminophores (3) is covalently attached to a single base in the DNA strand (11). 3. De methode volgens een van de voorgaande conclusies, waarbij het manipuleren van de streng (11) omvat het onderwerpen van ten minste een deel van de streng (11) aan een vooraf bepaalde trekkracht en/of het uitrekken van ten minste een deel van de streng (11).The method according to any of the preceding claims, wherein manipulating the strand (11) comprises subjecting at least a portion of the strand (11) to a predetermined tensile force and/or stretching at least a portion of the strand (11). 4. De methode volgens een van de voorgaande conclusies, omvattende het bepalen van een reactiepositie op de streng (11) van een reagens (13) dat in wisselwerking staat met de streng (11), waarbij een of meer luminoforen (3) aan het reagens (13) zijn bevestigd, bij voorkeur covalent bevestigd, en/of waarbij de interactie van het reagens (13) met de streng (11) wordt geassocieerd met een optisch proces dat ten minste één luminescente eigenschap van ten minste één van de luminoforen (3) die aan de DNA-streng (11) bevestigd zijn.The method according to any of the preceding claims, comprising determining a reaction position on the strand (11) of a reagent (13) interacting with the strand (11), with one or more luminophores (3) attached to the reagent (13) are attached, preferably covalently attached, and/or wherein the interaction of the reagent (13) with the strand (11) is associated with an optical process that enhances at least one luminescent property of at least one of the luminophores ( 3) attached to the DNA strand (11). 5. De methode volgens een van de voorgaande conclusies, waarbij het bevestigen van handvatten (7; 7A, 7B) het bevestigen omvat van te onderscheiden handvatten (7A, 7B) aan de streng (11), bij voorkeur optisch te onderscheiden handvatten (7A, 7B).The method according to any of the preceding claims, wherein attaching handles (7; 7A, 7B) comprises attaching distinguishable handles (7A, 7B) to the string (11), preferably optically distinguishable handles (7A , 7B). 6. De methode volgens een van de voorgaande conclusies, waarbij ten minste enkele van de luminoforen (3) onderling verschillende optische eigenschappen hebben, b.v. verschillende absorptie- en/of emissiespectra, verstrooiing hebbend, en/of waarbij de streng (11) is voorzien van handvatten (7A, 7B) met onderling verschillende optische eigenschappen, b.v. met verschillende absorptie- en/of emissiespectra, verstrooiing, en het bepalen van een richting van ten minste een deel van de DNA-streng (11) op basis van de respectievelijke verschillende optische eigenschappen.The method according to any one of the preceding claims, wherein at least some of the phosphors (3) have mutually different optical properties, e.g. having different absorption and/or emission spectra, scattering, and/or wherein the strand (11) is provided with handles (7A, 7B) with mutually different optical properties, e.g. having different absorption and/or emission spectra, scattering, and determining a direction of at least part of the DNA strand (11) based on the respective different optical properties. 7. De methode volgens een van de voorgaande conclusies, omvattende het bepalen van een tijdsafhankelijk gedrag van ten minste een van: een positie van ten minste een deel van de streng (11); een positie van een deel van de streng (11) ten opzichte van een of meer andere delen van de streng (11); en een reactiepositie op de streng (11) van een reagens (13) dat in wisselwerking staat met de streng (11).The method of any one of the preceding claims, comprising determining a time-dependent behavior of at least one of: a position of at least a portion of the strand (11); a position of a part of the strand (11) relative to one or more other parts of the strand (11); and a reaction site on the strand (11) of a reagent (13) interacting with the strand (11). 8. De methode volgens een van de voorgaande conclusies, waarbij de stap van het verschaffen van de DNA-streng (11) die een of meer luminoforen (3) omvat die covalent aan de streng (11) zijn bevestigd op een of meer vooraf bepaalde posities langs de streng (11) de stappen omvat van: het verschaffen van een oligomeer (4); covalent bevestigen van een luminofoor (3) aan het oligomeer (4) waardoor een optisch gelabeld oligomeer (4) wordt verschaft; het verschaffen van een dubbelstrengs DNA-streng (11); het vervangen van een sequentie van de DNA-streng (11) door het optisch gelabelde oligomeer (4).The method according to any of the preceding claims, wherein the step of providing the DNA strand (11) comprising one or more luminophores (3) covalently attached to the strand (11) at one or more predetermined positions along the strand (11) comprises the steps of: providing an oligomer (4); covalently attaching a luminophore (3) to the oligomer (4) to provide an optically labeled oligomer (4); providing a double-stranded DNA strand (11); replacing a sequence of the DNA strand (11) with the optically labeled oligomer (4). 9. De methode volgens een van de voorgaande conclusies, waarbij de DNA-streng (11) een laesie omvat op een vooraf bepaalde positie ten opzichte van de positie van de een of meer luminoforen (3).The method according to any of the preceding claims, wherein the DNA strand (11) comprises a lesion at a predetermined position relative to the position of the one or more luminophores (3). 10. Een DNA-streng (11) voor de methode volgens een van de voorgaande conclusies, omvattende een veelvoud van luminoforen (3) die covalent aan de streng (11) zijn bevestigd op een veelvoud van vooraf bepaalde posities langs de streng (11), en/of omvattende een of meer luminoforen (3) die covalent aan de streng (11) zijn bevestigd en een of meer laesies op een respectievelijk vooraf bepaalde positie ten opzichte van de positie van de een of meer luminoforen {3}, en waarbij de DNA-streng (11) is voorzien van handvatgroepen (5; 5A, 5B) voor bevestiging aan vangbare en/of manipuleerbare handvatten (7; 7A, 7B), b.v. polystyreenkralen voor optische vangst, magnetische bolletjes voor magnetische vangst, enz.A DNA strand (11) for the method of any preceding claim comprising a plurality of luminophores (3) covalently attached to the strand (11) at a plurality of predetermined positions along the strand (11) , and/or comprising one or more luminophores (3) covalently attached to the strand (11) and one or more lesions at a respective predetermined position relative to the position of the one or more luminophores {3}, and wherein the DNA strand (11) is provided with handle groups (5; 5A, 5B) for attachment to catchable and/or manipulable handles (7; 7A, 7B), e.g. polystyrene beads for optical capture, magnetic beads for magnetic capture, etc. 11. DNA-streng (11) volgens conclusie 10, waarbij de handvatgroepen (5A, 5B) verschillend zijn voor selectieve hechting aan onderscheidbare handvatten (7A, 7B).The DNA strand (11) of claim 10, wherein the handle groups (5A, 5B) are different for selective attachment to distinct handles (7A, 7B). 12. De DNA-streng (11) volgens een van de conclusies 10-11, waarbij het veelvoud van luminoforen (3) in hoofdzaak op gelijke afstand langs de DNA-streng (11) is bevestigd.The DNA strand (11) according to any one of claims 10-11, wherein the plurality of luminophores (3) are attached substantially equidistant along the DNA strand (11). 13. DNA-streng (11) volgens een van de conclusies 10-12, waarbij de DNA-streng (11) een veelvoud van in hoofdzaak identieke sequenties omvat, waarbij elk van de sequenties is voorzien van een of meer van het veelvoud aan luminoforen (3) covalent bevestigd aan de sequentie, in welk geval het veelvoud van in hoofdzaak identieke sequenties hetzelfde langs de DNA-streng (11) kan zijn georiënteerd.The DNA strand (11) of any one of claims 10-12, wherein the DNA strand (11) comprises a plurality of substantially identical sequences, each of the sequences being provided with one or more of the plurality of luminophores (3) covalently attached to the sequence, in which case the plurality of substantially identical sequences may be oriented the same along the DNA strand (11). 14. DNA-streng (11) volgens een van de conclusies 10-13, waarbij ten minste enkele van de luminoforen (3) onderling verschillende optische eigenschappen hebben, b.v. verschillende absorptie- en/of emissiespectra, verstrooiing hebbend en/of waarbij de streng (11) is voorzien van handvatten (7; 7A, 7B) met onderling verschillende optische eigenschappen, b.v. met verschillende absorptie- en/of emissiespectra, verstrooiing.DNA strand (11) according to any one of claims 10-13, wherein at least some of the luminophores (3) have mutually different optical properties, e.g. having different absorption and/or emission spectra, scattering and/or wherein the strand (11) is provided with handles (7; 7A, 7B) with mutually different optical properties, e.g. with different absorption and/or emission spectra, scattering.
NL2029858A 2021-11-22 2021-11-22 Detection of a biomolecular process NL2029858B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL2029858A NL2029858B1 (en) 2021-11-22 2021-11-22 Detection of a biomolecular process
PCT/EP2022/082010 WO2023088906A1 (en) 2021-11-22 2022-11-15 Detection of a biomolecular process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2029858A NL2029858B1 (en) 2021-11-22 2021-11-22 Detection of a biomolecular process

Publications (1)

Publication Number Publication Date
NL2029858B1 true NL2029858B1 (en) 2023-06-13

Family

ID=80625432

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2029858A NL2029858B1 (en) 2021-11-22 2021-11-22 Detection of a biomolecular process

Country Status (1)

Country Link
NL (1) NL2029858B1 (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018218A1 (en) * 1993-02-01 1994-08-18 Seq, Ltd. Methods and apparatus for dna sequencing
JP2003189852A (en) * 2001-12-26 2003-07-08 Olympus Optical Co Ltd Base sequence-determining apparatus and base sequence- determining method
US20070069119A1 (en) * 2005-09-23 2007-03-29 Massachusetts Institute Of Technology Optical trapping with a semiconductor
US20080286878A1 (en) * 2007-03-27 2008-11-20 Lehigh University Systems, Compositions And Methods For Nucleic Acid Detection
WO2014196854A1 (en) 2013-06-03 2014-12-11 Stichting Vu-Vumc Method and system for imaging a molecular strand
WO2016129994A1 (en) 2015-02-09 2016-08-18 Stichting Vu Apparatus and method for controlling a plurality of optical traps
WO2019098839A1 (en) 2017-11-17 2019-05-23 Stichting Vu Method and system for optical force measurement
WO2019139473A1 (en) 2018-01-09 2019-07-18 Stichting Vu Methods and systems for supercoiling dna
WO2019151864A1 (en) 2018-02-05 2019-08-08 Lumicks Technologies B.V. Methods and devices for determining a guest structure on a host structure
WO2020130812A1 (en) 2018-12-17 2020-06-25 Lumicks Technologies B.V. Microscopy method and system

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018218A1 (en) * 1993-02-01 1994-08-18 Seq, Ltd. Methods and apparatus for dna sequencing
JP2003189852A (en) * 2001-12-26 2003-07-08 Olympus Optical Co Ltd Base sequence-determining apparatus and base sequence- determining method
US20070069119A1 (en) * 2005-09-23 2007-03-29 Massachusetts Institute Of Technology Optical trapping with a semiconductor
US20080286878A1 (en) * 2007-03-27 2008-11-20 Lehigh University Systems, Compositions And Methods For Nucleic Acid Detection
WO2014196854A1 (en) 2013-06-03 2014-12-11 Stichting Vu-Vumc Method and system for imaging a molecular strand
US9766180B2 (en) 2013-06-03 2017-09-19 Stichting Vu-Vumc Method and system for imaging a molecular strand
WO2016129994A1 (en) 2015-02-09 2016-08-18 Stichting Vu Apparatus and method for controlling a plurality of optical traps
WO2019098839A1 (en) 2017-11-17 2019-05-23 Stichting Vu Method and system for optical force measurement
WO2019139473A1 (en) 2018-01-09 2019-07-18 Stichting Vu Methods and systems for supercoiling dna
WO2019151864A1 (en) 2018-02-05 2019-08-08 Lumicks Technologies B.V. Methods and devices for determining a guest structure on a host structure
WO2020130812A1 (en) 2018-12-17 2020-06-25 Lumicks Technologies B.V. Microscopy method and system

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Methods in Molecular Biology books series", 2017, SPRINGER, article "Optical tweezers - methods and protocols"
ASHKIN ET AL., OPT LETT, vol. 11, 1986, pages 288
BROUWER ET AL., NATURE, vol. 535, no. 7613, 2016, pages 566 - 569, Retrieved from the Internet <URL:https://doi.org/10.1038/nature18643>
CANDELLI ET AL., PHYS. CHEM. CHEM. PHYS., vol. 13, 2011, pages 7263 - 7272
HELLER ET AL., CHEM.PHYS.CHEM., vol. 15, 2014, pages 727 - 733, Retrieved from the Internet <URL:https://doi.orq/10.1002/cphc.201300813>
LOPARO ET AL., PNAS, vol. 108, 2011, pages 3584 - 3589, Retrieved from the Internet <URL:www.pnas.org/cgi/doi/10.1073/pnas.1018824108>
NEWTON ET AL., NATURE STRUCTURAL & MOLECULAR BIOLOGY, vol. 26, 2019, pages 185 - 192, Retrieved from the Internet <URL:https://doi.org/10.1038/s41594-019-0188-z>
SIRINAKIS GEORGE ET AL: "Combined versatile high-resolution optical tweezers and single-molecule fluorescence microscopy", REVIEW OF SCIENTIFIC INSTRUMENTS, AMERICAN INSTITUTE OF PHYSICS, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747, vol. 83, no. 9, 17 September 2012 (2012-09-17), pages 93708 - 93708, XP012162639, ISSN: 0034-6748, [retrieved on 20120917], DOI: 10.1063/1.4752190 *

Similar Documents

Publication Publication Date Title
JP6654616B2 (en) Sub-diffraction limit image resolution and other imaging techniques
US11352667B2 (en) Nucleic acid sequencing
US7351538B2 (en) Systems and methods for detecting and analyzing polymers
US10266876B2 (en) Multiplex detection of molecular species in cells by super-resolution imaging and combinatorial labeling
US20170327888A1 (en) Triggered assembly of metafluorophores
Yi et al. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy
EP4060327A1 (en) Sub-diffraction limit image resolution in three dimensions
US20120135410A1 (en) Method for imaging on thin solid-state interface between two fluids
Beater et al. Choosing dyes for cw-STED nanoscopy using self-assembled nanorulers
JP3996056B2 (en) Method and apparatus for reading reporter label beads
Halstead et al. TRICK: a single-molecule method for imaging the first round of translation in living cells and animals
Achimovich et al. Enabling technologies in super-resolution fluorescence microscopy: reporters, labeling, and methods of measurement
Jung et al. Quantitative microscopy based on single-molecule fluorescence
Frischknecht et al. Imaging today's infectious animalcules
NL2029858B1 (en) Detection of a biomolecular process
Hughes et al. Single molecule techniques in DNA repair: a primer
WO2023088906A1 (en) Detection of a biomolecular process
Sonnleitner et al. High-throughput scanning with single-molecule sensitivity
Chakraborty et al. Determination of rate constants for conformational changes of RNA helicases by single-molecule FRET TIRF microscopy
EP3943945A1 (en) Multiplexed cell phototagging
Gansen Chromatin at the Nanolevel-Development of a single molecule FRET experiment and analysis of the structure and stability of individual nucleosomes
Jin et al. Single-Molecule DNA Visualization
Howell et al. Optical single-molecule recordings in membrane tethers
Axmann et al. Single‐Molecule Microscopy in the Life Sciences
Feng et al. Measuring transition paths of protein folding with single-molecule FRET and Zero-mode waveguides